ImmVirX - Crunchbase Company Profile & Funding

Q: Who invested in ImmVirX?

ImmVirX has 2 investors including OneVentures And Acorn Capital.

Q: When was the last funding round for ImmVirX?

ImmVirX closed its last funding round on obfuscated from a Series B round.

Overview

ImmVirX

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About ImmVirX

CB Rank

88761

ImmVirX devolops novel oncolytic viruses to create powerful new cancer immunotherapy combinations.

Founded

obfuscation

Private

Series B

New Lambton, New South Wales, Australia

11-50

www.immvirx.com/

Health Care

Health Diagnostics

Funding Rounds

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Series A

OBF

obfuscation

Details

Legal Name

ImmVirX Pty. Ltd.

Operating Status

Active

Company Type

For Profit

About the Company

ImmVirX hopes to advance a new generation of cancer treatments,By developing a novel oncolytic immunotherapy that targets cancer indications with high unmet need

Contact Email

info@immvirx.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Oncolytic Virus Therapeutics

Engineered viruses designed to selectively infect and destroy cancer cells while stimulating an immune response against tumors.

Research & Development

ImmVirX is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - ImmVirX	2	obfuscated obfuscation	OneVentures	Series B
obfuscated obfuscation	Series B - ImmVirX	2	obfuscated obfuscation	OneVentures	Series B
obfuscated obfuscation	Series B - ImmVirX	2	obfuscated obfuscation	OneVentures	Series B
obfuscated obfuscation	Series B - ImmVirX	2	obfuscated obfuscation	OneVentures	Series B
obfuscated obfuscation	Series B - ImmVirX	2	obfuscated obfuscation	OneVentures	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - ImmVirX	2	obfuscated obfuscation	OneVentures	Series B
obfuscated obfuscation	Series B - ImmVirX	2	obfuscated obfuscation	OneVentures	Series B
obfuscated obfuscation	Series B - ImmVirX	2	obfuscated obfuscation	OneVentures	Series B
obfuscated obfuscation	Series B - ImmVirX	2	obfuscated obfuscation	OneVentures	Series B
obfuscated obfuscation	Series B - ImmVirX	2	obfuscated obfuscation	OneVentures	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
OneVentures	Yes	Series B - ImmVirX	Jeannie Joughin
OneVentures	Yes	Series B - ImmVirX	Jeannie Joughin
OneVentures	Yes	Series B - ImmVirX	Jeannie Joughin
OneVentures	Yes	Series B - ImmVirX	Jeannie Joughin
OneVentures	Yes	Series B - ImmVirX	Jeannie Joughin